Nexxys™
Culture in our lab
Overview
Service Packages
Scale-out capacity
Process characterization
Process development & optimization
Process model
development
Our Bioreactors
250mL bench-scale single-use bioreactor
5L single-use bioreactor
Applications
Protein therapeutics
Viral vectors
Synthetic biology
Console
Stratyx™
Resources
Resources
White papers
Case studies
Documentation
Product updates
Blog posts
Announcements
Press
View all
Announcement
Culture Biosciences unveils Stratyx™ 250, the first cloud-integrated, mobile bioreactor for cell culture process development
Read more
Documentation
Stratyx™ 250 Hardware & Single Use Technical Specifications
Read more
About
Log in
Contact
Announcement
Culture Biosciences unveils Stratyx™ 250, the first cloud-integrated, mobile bioreactor for cell culture process development
Read more
Resources
All
White paper
Case study
Documentation
Product update
Blog post
Announcement
Press
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Blog post
Insights from the ESACT Bioprocess Modeling Course 2023
November 7, 2023
Blog post
Product update
Culture Solutions: Systematic & Automated Analysis for Cell Line Screening
October 20, 2023
Product update
Blog post
The Mysterious Case of the Missing Glucose
August 23, 2023
Blog post
Product update
New Feature Release: Live Data in Console
July 21, 2023
Product update
Announcement
Biotech Executive Beth Thompson-Webb Joins Culture Biosciences’ Board Of Directors
July 13, 2023
Announcement
Announcement
Culture Biosciences And Cytiva Team Up To Innovate In Upstream Bioprocessing To Advance The Development And Manufacturing Of New Therapies
June 15, 2023
Announcement
Announcement
Culture Biosciences Establishes Advisory Board Of Biotech And Biopharma Executives To Guide The Corporate Strategy And Accelerate Growth
June 1, 2023
Announcement
Press
Surfing the Waves in Upstream Bioprocess Development – Molecule to Market Podcast with Culture’s CEO, Will Patrick
May 5, 2023
Press
Case study
MilliporeSigma Achieved Significant Increases in the Final Titers for Multiple CHOZN® Cell Lines, Using Culture Biosciences’ Cloud Bioreactor Platform
April 4, 2023
Case study
Previous
Load more
Subscribe to our newsletter